Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hille

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
IEEE Open Journal of Engineering in Medicine and Biology|August 28, 2024
A Review and Tutorial on Machine Learning-Enabled Radar-Based Biomedical MonitoringDaniel Krauss, Lukas Engel, Tabea Ott, et al.
Pediatric Research|March 22, 2006
Lipid profile and carotid intima-media thickness in a prospective cohort of very preterm subjects at age 19 years: effects of early growth and current body compositionMartijn J J Finken, Akin Inderson, Nadine Van Montfoort, et al.
Journal of Thrombosis and Haemostasis : JTH|August 31, 2004
Preeclampsia and its interaction with common variants in thrombophilia genesM P M De Maat, M W J C Jansen, E T M Hille, et al.
The Review of Scientific Instruments|February 8, 2013
Endstation for ultrafast magnetic scattering experiments at the free-electron laser in HamburgL Müller, C Gutt, S Streit-Nierobisch, et al.
The Oncologist|January 3, 2012
Age-specific nonpersistence of endocrine therapy in postmenopausal patients diagnosed with hormone receptor-positive breast cancer: a TEAM study analysisWillemien van de Water, Esther Bastiaannet, Elysée T M Hille, et al.
Breast Cancer Research and Treatment|March 29, 2012
Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side studyJ G H van Nes, D B Y Fontein, E T M Hille, et al.
The Oncologist|December 25, 2012
Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: a tamoxifen exemestane adjuvant multinational study analysisWillemien van de Water, Caroline Seynaeve, Esther Bastiaannet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2012
Relationship between specific adverse events and efficacy of exemestane therapy in early postmenopausal breast cancer patientsD B Y Fontein, D Houtsma, E T M Hille, et al.
Lancet (London, England)|January 21, 2011
Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trialCornelis J H van de Velde, Daniel Rea, Caroline Seynaeve, et al.
JAMA|February 10, 2012
Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancerWillemien van de Water, Christos Markopoulos, Cornelis J H van de Velde, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
IEEE Open Journal of Engineering in Medicine and Biology|August 28, 2024
A Review and Tutorial on Machine Learning-Enabled Radar-Based Biomedical MonitoringDaniel Krauss, Lukas Engel, Tabea Ott, et al.
Pediatric Research|March 22, 2006
Lipid profile and carotid intima-media thickness in a prospective cohort of very preterm subjects at age 19 years: effects of early growth and current body compositionMartijn J J Finken, Akin Inderson, Nadine Van Montfoort, et al.
Journal of Thrombosis and Haemostasis : JTH|August 31, 2004
Preeclampsia and its interaction with common variants in thrombophilia genesM P M De Maat, M W J C Jansen, E T M Hille, et al.
The Review of Scientific Instruments|February 8, 2013
Endstation for ultrafast magnetic scattering experiments at the free-electron laser in HamburgL Müller, C Gutt, S Streit-Nierobisch, et al.
The Oncologist|January 3, 2012
Age-specific nonpersistence of endocrine therapy in postmenopausal patients diagnosed with hormone receptor-positive breast cancer: a TEAM study analysisWillemien van de Water, Esther Bastiaannet, Elysée T M Hille, et al.
Breast Cancer Research and Treatment|March 29, 2012
Quality of life in relation to tamoxifen or exemestane treatment in postmenopausal breast cancer patients: a Tamoxifen Exemestane Adjuvant Multinational (TEAM) Trial side studyJ G H van Nes, D B Y Fontein, E T M Hille, et al.
The Oncologist|December 25, 2012
Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: a tamoxifen exemestane adjuvant multinational study analysisWillemien van de Water, Caroline Seynaeve, Esther Bastiaannet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 7, 2012
Relationship between specific adverse events and efficacy of exemestane therapy in early postmenopausal breast cancer patientsD B Y Fontein, D Houtsma, E T M Hille, et al.
Lancet (London, England)|January 21, 2011
Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trialCornelis J H van de Velde, Daniel Rea, Caroline Seynaeve, et al.
JAMA|February 10, 2012
Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancerWillemien van de Water, Christos Markopoulos, Cornelis J H van de Velde, et al.
Pageof 9